OTCMKTS:SCIE

SpectraScience Competitors

$0.0002

0.00 (0.00 %)

(As of 04/12/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.00

Now: $0.00▼

$0.00

50-Day Range N/A

52-Week Range

$0.00

Now: $0.00▼

$0.01

Volume17.75 million shs

Average Volume221.03 million shs

Market Capitalization$176,734.00

P/E RatioN/A

Dividend YieldN/A

Beta0.96

SpectraScience (OTCMKTS:SCIE) Vs. IMRSQ, ECTE, ULGX, AKSY, ESMC, and HRTT

Should you be buying SCIE stock or one of its competitors? Companies in the industry of "electromedical equipment" are considered alternatives and competitors to SpectraScience, including IMRIS (IMRSQ), Echo Therapeutics (ECTE), Urologix (ULGX), Aksys (AKSY), Escalon Medical (ESMC), and Heart Tronics (HRTT).

SpectraScience vs. IMRIS Stock

SpectraScience (OTCMKTS:SCIE) and IMRIS (OTCMKTS:IMRSQ) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

Profitability

This table compares SpectraScience and IMRIS's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SpectraScience	N/A	N/A	N/A
IMRIS	N/A	N/A	N/A

Earnings and Valuation

This table compares SpectraScience and IMRIS's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SpectraScience	N/A	N/A	N/A	N/A	N/A
IMRIS	N/A	N/A	N/A	N/A	N/A

Risk & Volatility

SpectraScience has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, IMRIS has a beta of -10.69, meaning that its share price is 1,169% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for SpectraScience and IMRIS, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SpectraScience	0	0	0	0	N/A
IMRIS	0	0	0	0	N/A

Summary

SpectraScience beats IMRIS on 1 of the 1 factors compared between the two stocks.

SpectraScience vs. Echo Therapeutics Stock

SpectraScience (OTCMKTS:SCIE) and Echo Therapeutics (OTCMKTS:ECTE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

Profitability

This table compares SpectraScience and Echo Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SpectraScience	N/A	N/A	N/A
Echo Therapeutics	N/A	N/A	N/A

Earnings and Valuation

This table compares SpectraScience and Echo Therapeutics' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SpectraScience	N/A	N/A	N/A	N/A	N/A
Echo Therapeutics	N/A	N/A	N/A	N/A	N/A

Risk & Volatility

SpectraScience has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, Echo Therapeutics has a beta of 7.09, meaning that its share price is 609% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for SpectraScience and Echo Therapeutics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SpectraScience	0	0	0	0	N/A
Echo Therapeutics	0	0	0	0	N/A

Summary

Echo Therapeutics beats SpectraScience on 1 of the 1 factors compared between the two stocks.

SpectraScience vs. Urologix Stock

SpectraScience (OTCMKTS:SCIE) and Urologix (OTCMKTS:ULGX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

Profitability

This table compares SpectraScience and Urologix's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SpectraScience	N/A	N/A	N/A
Urologix	N/A	N/A	N/A

Earnings and Valuation

This table compares SpectraScience and Urologix's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SpectraScience	N/A	N/A	N/A	N/A	N/A
Urologix	N/A	N/A	N/A	N/A	N/A

Risk & Volatility

SpectraScience has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, Urologix has a beta of 2.11, meaning that its share price is 111% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for SpectraScience and Urologix, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SpectraScience	0	0	0	0	N/A
Urologix	0	0	0	0	N/A

Summary

Urologix beats SpectraScience on 1 of the 1 factors compared between the two stocks.

SpectraScience vs. Aksys Stock

SpectraScience (OTCMKTS:SCIE) and Aksys (OTCMKTS:AKSY) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for SpectraScience and Aksys, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SpectraScience	0	0	0	0	N/A
Aksys	0	0	0	0	N/A

Risk & Volatility

SpectraScience has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, Aksys has a beta of -6.76, meaning that its share price is 776% less volatile than the S&P 500.

Profitability

This table compares SpectraScience and Aksys' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SpectraScience	N/A	N/A	N/A
Aksys	N/A	N/A	N/A

Earnings and Valuation

This table compares SpectraScience and Aksys' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SpectraScience	N/A	N/A	N/A	N/A	N/A
Aksys	N/A	N/A	N/A	N/A	N/A

Summary

SpectraScience beats Aksys on 1 of the 1 factors compared between the two stocks.

SpectraScience vs. Escalon Medical Stock

Escalon Medical (OTCMKTS:ESMC) and SpectraScience (OTCMKTS:SCIE) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Analyst Recommendations

This is a breakdown of current recommendations for Escalon Medical and SpectraScience, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Escalon Medical	0	0	0	0	N/A
SpectraScience	0	0	0	0	N/A

Earnings & Valuation

This table compares Escalon Medical and SpectraScience's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Escalon Medical	$9.40 million	N/A	$-650,000.00	N/A	N/A
SpectraScience	N/A	N/A	N/A	N/A	N/A

SpectraScience has lower revenue, but higher earnings than Escalon Medical.

Profitability

This table compares Escalon Medical and SpectraScience's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Escalon Medical	-15.54%	-136.63%	-26.09%
SpectraScience	N/A	N/A	N/A

Risk and Volatility

Escalon Medical has a beta of -0.86, meaning that its share price is 186% less volatile than the S&P 500. Comparatively, SpectraScience has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500.

Summary

SpectraScience beats Escalon Medical on 4 of the 5 factors compared between the two stocks.

SpectraScience vs. Heart Tronics Stock

SpectraScience (OTCMKTS:SCIE) and Heart Tronics (OTCMKTS:HRTT) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability.

Analyst Ratings

This is a summary of recent ratings for SpectraScience and Heart Tronics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SpectraScience	0	0	0	0	N/A
Heart Tronics	0	0	0	0	N/A

Earnings and Valuation

This table compares SpectraScience and Heart Tronics' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SpectraScience	N/A	N/A	N/A	N/A	N/A
Heart Tronics	N/A	N/A	N/A	N/A	N/A

Profitability

This table compares SpectraScience and Heart Tronics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SpectraScience	N/A	N/A	N/A
Heart Tronics	N/A	N/A	N/A

Risk and Volatility

SpectraScience has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, Heart Tronics has a beta of 1024.78, meaning that its share price is 102,378% more volatile than the S&P 500.

Summary

Heart Tronics beats SpectraScience on 1 of the 1 factors compared between the two stocks.